Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
Top Cited Papers
- 31 July 2006
- journal article
- review article
- Published by Wiley in Angewandte Chemie-International Edition
- Vol. 45 (31), 5072-5129
- https://doi.org/10.1002/anie.200600350
Abstract
To create a drug, nature's blueprints often have to be improved through semisynthesis or total synthesis (chemical postevolution). Selected contributions from industrial and academic groups highlight the arduous but rewarding path from natural products to drugs. Principle modification types for natural products are discussed herein, such as decoration, substitution, and degradation. The biological, chemical, and socioeconomic environments of antibacterial research are dealt with in context. Natural products, many from soil organisms, have provided the majority of lead structures for marketed anti‐infectives. Surprisingly, numerous “old” classes of antibacterial natural products have never been intensively explored by medicinal chemists. Nevertheless, research on antibacterial natural products is flagging. Apparently, the “old fashioned” natural products no longer fit into modern drug discovery. The handling of natural products is cumbersome, requiring nonstandardized workflows and extended timelines. Revisiting natural products with modern chemistry and target‐finding tools from biology (reversed genomics) is one option for their revival.Keywords
This publication has 513 references indexed in Scilit:
- The Impact of Bacterial Genomics on Natural Product ResearchAngewandte Chemie-International Edition, 2005
- Synthesis of L‐Furanomycin and Its Analogues via FuroisoxazolinesEuropean Journal of Organic Chemistry, 2005
- Alicyclic β-amino acids in Medicinal ChemistryAmino Acids, 2005
- Target-Accelerated Combinatorial Synthesis and Discovery of Highly Potent Antibiotics Effective Against Vancomycin-Resistant BacteriaAngewandte Chemie, 2000
- Target-Accelerated Combinatorial Synthesis and Discovery of Highly Potent Antibiotics Effective Against Vancomycin-Resistant BacteriaAngewandte Chemie-International Edition, 2000
- Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicingJournal of Molecular Biology, 1994
- Screening of natural products for antimicrobial agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Synthesis of (S,S)‐Diisotyrosine and Its Incorporation in an Ansa TripeptideAngewandte Chemie-International Edition, 1989
- The chemical structure of capreomycinCellular and Molecular Life Sciences, 1976